Food preferences may shift toward lighter, lower-fat options because heavy meals become uncomfortable
Overview Retatrutide is a synthetic, long-acting triple agonist that targets three distinct hormonal receptors: the glucagon-like pep-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor (GCGR)
Wegovy and Ozempic are expected to be selected for the next round of Medicare price negotiations, due to take place next year with price reductions effective starting in 2027
If you have chronic kidney disease, heart failure, liver disease, or take medications that affect electrolyte balance (such as diuretics, ACE inhibitors, or NSAIDs), discuss electrolyte supplementation with your doctor before starting